Your Interactive Patient Guide to Hidradenitis Suppurativa
Your Interactive Patient Guide to Hidradenitis Suppurativa (HS)
Related Articles
Prospective Trial of Sacroiliac Joint Fusion Using… : Spine
h solid titanium plasma spray coated implants Summary of Background Data. A large literature base supports minimally invasive SIJF with TTI for chronic SIJ dysfunction.…
Arthritis Care & Research: Vol 77, No 4
Arthritis Care & Research is a rheumatology journal from the American College of Rheumatology and the Association of Rheumatology Health Professionals.
Salmonella Surgical Site Infection After Cervical Spine Surgery
A 59-year-old man sustained a fall onto his head and was found to have dense bilateral upper extremity weakness worse than lower extremity and radiographic…
Risk Factors for Nonunion After Distal Phalangeal Fractures of the Hand
This study aimed to evaluate the risk factors for distal phalanx fracture nonunion.
Annual Meeting Abstracts
Submit your abstract to ACR Convergence. See submission & presentation guidelines. Also see permission & reprint policies & abstract embargo policy.
President’s Corner: The Practicing Rheumatologist – The Rheumatologist
Independent, community-based rheumatologists and rheumatology professionals represent a critical part of the ACR and ARP. My immense respect for clinicians grew while watching my husband,…
Barriers and Facilitators for Implementing Resilience Coaching for Youth with Chronic Musculoskeletal Pain: Pediatric Rheumatologists’ Perspectives
Objective Promoting Resilience in Stress Management (PRISM) is a resilience coaching program designed for adolescents with chronic illness. We aimed to examine the perceived feasibility,…
Global Community
Learn more about the American College of Rheumatology’s education resources for the global rheumatology community.
Efficacy and Safety of Zimlovisertib, Ritlecitinib and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Objective To evaluate the efficacy and safety of zimlovisertib (interleukin-1 receptor-associated kinase 4 inhibitor) in combination with ritlecitinib (a Janus kinase [JAK] 3 and tyrosine…